SCHEMBL610882

SCHEMBL610882

CC(C)(C)OC(=O)CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL140084 0.80
SCHEMBL27815234 0.79 ALDH1A1 (0.35)
SCHEMBL10606 0.79 HDAC6 (0.37)
SCHEMBL25946603 0.77 PPARA (0.33)
SCHEMBL6154635 0.77 CYP2D6 (0.45)
SCHEMBL241533 0.77 DGAT1 (0.46)
SCHEMBL644646 0.77 TSHR (0.45)
SCHEMBL2963000 0.76 HDAC6 (0.42)
SCHEMBL418887 0.75 EPHX2 (0.39)
SCHEMBL63935 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118812474-A Water-soluble coumarin-based light-controlled latent incense body and preparation method and application thereof 上海应用技术大学 2024-10-22 CN claimed
WO-2022219485-A1 A SCALABLE PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE GLYCINE TERT-BUTYL ESTER AND ITS SALT THEREOF HIKAL LIMITED (IN) 2022-10-20 WO claimed
CN-113880850-B Gadobutrol intermediate, preparation method and application in gadobutrol preparation 苏州百灵威超精细材料有限公司 2022-10-04 CN claimed
CN-113880850-A Gadobutrol intermediate, preparation method and application in gadobutrol preparation 苏州百灵威超精细材料有限公司 2022-01-04 CN claimed
CN-113461591-A Preparation method of precursor raw material Pht-AEEA-AEEA for side chain of Somalutide 浙江泽瑞生物医药有限公司 2021-10-01 CN claimed
CN-112961113-A Preparation method of ambroxol hydrochloride impurity 北京新康哌森医药科技有限公司 2021-06-15 CN claimed
CN-110078644-B preparation method of [2- [1- (Fmoc-amino) ethoxy ] acetic acid 深圳市茵诺圣生物科技有限公司 2019-12-17 CN claimed
CN-103965047-B The preparation method of 3,3,3-trifluoroacetic acid and ester thereof XI'AN INST. OF MODERN CHEMISTRY (CN) 2015-10-28 CN claimed
CN-104418707-A Natural product fructus psoraleae phenol and asymmetric synthesis method of enantiomer thereof UNIV FUDAN 2015-03-18 CN claimed
CN-103965047-A Method for preparing 3,3,3-trifluoropropionic acid and ester thereof XIAN MODERN CHEMISTRY RES INST 2014-08-06 CN claimed
CN-101628894-B Preparation method of 3-(S)-amino-2, 3,4, 5-tetrahydro-2-oxo-1H-1-benzoaza-1-tert-butyl acetate ZHEJIANG SANHE PHARMACEUTICAL CHEMICAL CO LTD 2011-06-29 CN claimed
CN-101628894-A Preparation method of 3- (S) -amino-2, 3,4, 5-tetrahydro-2-oxo-1H-1-benzazepine-1-tert-butyl acetate ZHEJIANG SANHE PHARMACEUTICAL 2010-01-20 CN claimed
WO-2009056077-A2 A NEW METHOD OF MANUFACTURING 2-(6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-LH-PYRROLIZINE-5-YL)ACETIC ACID (LICOFELONE) ZENTIVA, A.S. (CZ) 2009-05-07 WO claimed
US-20250353864-A1 INDAZOLE CONTAINING MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2025-11-20 US disclosed
EP-4536224-A1 INDAZOLE CONTAINING MACROCYCLES AND THEIR USE Blossomhill Therapeutics, Inc. (US) 2025-04-16 EP disclosed
CN-119421709-A Indazole-containing macrocyclic compounds and uses thereof 荣山医药股份有限公司 2025-02-11 CN disclosed
EP-0049505-A2 Substituted caprolactam derivatives, a process for preparing and a pharmaceutical composition containing the same, and intermediates MERCK & CO. INC. (US) 1982-04-14 EP disclosed
EP-0046289-A2 Substituted enantholactam derivatives as antihypertensives, a process for preparing and a pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed
EP-0046292-A1 Substituted caprylolactam derivatives as antihypertensives, process for preparing and pharmaceutical composition comprising them MERCK & CO. INC. (US) 1982-02-24 EP disclosed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed